Researchers uncover the fundamental importance of AMPA receptor biogenesis for brain function
For the first time, Dr. Aline Brechet, Dr. Jochen Schwenk and Prof. Dr. Bernd Fakler, together with geneticists from the University of Leipzig and Paris, France, uncovered the significance of the molecular assembly processes – called biogenesis – of AMPA-type glutamate receptors for proper operation of the human brain.
Schematic illustration of AMPA receptor biogenesis in the endoplasmic reticulum (ER) with subsequent delivery to the synaptic compartment. Upper right: pedigree of one of the discovered FRRS1I families.
Graphics: Bernd Fakler
AMPA receptors, the most abundant neurotransmitter receptors in the brain, are multi-protein complexes that are assembled intracellularly and are subsequently transported to the synapses where they are responsible for signal transduction and information processing. Defective receptor assembly resulting from genetic mutations causes severe intellectual disability with cognitive impairment and epileptic activity.
The results introduce an unexpected mechanism for the control of higher brain functions in humans. The biologists and geneticists recently published their findings in the online-journal Nature Communications.
Using high-resolution proteomic analysis, the scientists identified a population of AMPA receptors in brain membrane preparations that fundamentally differs in their subunit composition from synaptic AMPA receptors. These newly identified complexes are restricted to the endoplasmic reticulum and represent a transitional step in the biogenesis of synaptic receptor complexes.
When formation of these transitional complexes is inhibited via virus administered to rodent brain, the number of synaptic AMPA receptors is drastically reduced. As a result, the researchers detected a largely disturbed synaptic signal transduction.
In the human brain, impairment of AMPA receptor biogenesis may be invoked by mutations in the main subunit of the transitional complexes, the so-called FRRS1I protein. The researchers identified there different FRRS1l mutations in three distinct families where homozygously affected patients (mutations in both, maternal and paternal alleles) suffered from severe brain dysfunction: all patients demonstrated largely impaired intellectual abilities, delayed or complete lack of speech development and epileptic activity.
Interestingly, the diseased brains failed to show any significant alterations in morphology. For the scientists, these observations are indicative for functional deficiencies induced by the impaired AMPA receptor biogenesis as the disease-causing mechanism.
As early as 2012 Fakler’s group has shown that AMPA receptors in the brains are assembled from an array of more than 30 different proteins. Quite a number of these proteins - including the FRRS1I protein - lack annotation of primary function(s). With their current work, the scientists have shown how important these ‘unknown’ protein components and research pursuing their molecular mode of action are for understanding higher brain functions.
The physiologists Jochen Schwenk and Bernd Fakler along with the neurobiologist Aline Brechet conduct research at the Institute of Physiology. Schwenk and Fakler also work at the Cluster of Excellence BIOSS Centre for Biological Signalling Studies at the University of Freiburg.
AMPA-receptor specific biogenesis complexes control synaptic transmission and intellectual ability. A. Brechet, R. Buchert, J. Schwenk, S. Boudkkazi, G. Zolles, K. Siquier-Pernet, I. Schaber, W. Bildl, A. Saadi, C. Bole-Feysot, P. Nitschke, A. Reis, H. Sticht, N. Al-Sanna’a, A. Rolfs, A. Kulik, U. Schulte, L. Colleaux, R. Abou Jamra and B. Fakler (2017) Nature Communications 8, 15910; doi: 10.1038/NCOMMS15910
Prof. Dr. Bernd Fakler
Institute of Physiology, Department II / BIOSS Centre for Biological Signalling Studies
University of Freiburg
Rudolf-Werner Dreier | Albert-Ludwigs-Universität Freiburg im Breisgau
Rochester scientists discover gene controlling genetic recombination rates
23.04.2018 | University of Rochester
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
23.04.2018 | Earth Sciences
23.04.2018 | Trade Fair News
23.04.2018 | Information Technology